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Abstract 
OBJECTIVE: The objective of this paper is to investigate the goals and variables employed in the machine learning and 
microsimulation studies for the prognosis of dementia. 
METHOD: According to preset protocols, the Pubmed, Socups and Web of Science databases were searched to find studies that 
matched the defined inclusion/exclusion criteria, and then its references were checked for new studies. A quality checklist 
assessed the selected studies, and removed the low quality ones. The remaining ones (included set) had their data extracted and 
summarized. 
RESULTS: The summary of the data of the 37 included studies showed that the most common goal of the selected studies was 
the prediction of the conversion from mild cognitive impairment to Alzheimer’s Disease, for studies that used machine learning, 
and cost estimation for the microsimulation ones. About the variables, neuroimaging was the most frequent used. 
CONCLUSIONS: The systematic literature review showed clear trends in prognosis of dementia research in what concerns 
machine learning techniques and microsimulation. 
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1. Introduction 
Life expectancy has been increasing over the years showing that the worldwide aging phenomenon is a reality. 
The World Health Organization Statistics1 states that in 66 countries, it has surpassed the age of 75. Factors like 
improvements in healthcare programs and socioeconomic conditions could be attributed as causes of this 
phenomenon and what it is known to be a consequence is the shift of the healthcare burden from infectious diseases 
to chronic conditions due to its relation to aging2. 
In this changing scenario, where the elderly population continually grows, a chronic condition that has gained 
interest in the health research, due to its severity and high prevalence among the elderly, is dementia. It refers to the 
decline in daily functioning and cognition, severe enough to increase mortality risks by at least two times3, having 
no disease modifying treatment available4. Furthermore, studies have shown that patients who suffer from dementia 
tend to have on average from 2 to 8 additional chronic diseases, characterizing a comorbidity, which can possibly 
accelerate their decline in daily functioning4,5.  
Further, another challenge related to this scenario concerns the clinical practice guidelines currently used by the 
physicians. As most of the health research is focused on specific diseases, these guidelines are usually concerned 
with a single disease. Also, as the elderly rarely participate in clinical trials, there are almost no guidelines for 
treating these patients. Consequently, the body of evidence in which physicians have to rely on elaborate treatments 
may not be accurate enough, to deal with dementia and comorbidities7,8,9. 
Yet, the increase in the incidence of these conditions is not being followed by an evolution in the care for the 
elderly population, who is likely to deal with poorer quality of life; loss of independence; psychological distress; 
longer hospital stays; more postoperative complications; higher mortality; and complex self-care needs that 
contribute towards the energy and financial burden of the patients10,11,12. Meanwhile, health institutions have to deal 
with the increase in healthcare costs, as more patients use public healthcare systems; there is a higher use of 
emergency facilities; accessibility; coordination; inadequate consultation times etc10,11,12. All the mentioned 
problems lead to an inefficient process of care that can affect patients in a negative way and also impact health 
institutions economically. 
Fortunately, the availability of health data is increasing regarding variety, volume and availability, leading to a 
positive impact on research outcomes, health economics and epidemiology13. This makes it possible to apply data 
analysis methods, such as machine learning and microsimulation, to produce knowledge-based frameworks that can 
provide models, identify patterns and clusters, derive predictors etc. The importance of applying these computer 
techniques in analyzing health data is that it can help develop prognostic information about conditions and their 
intrinsic mechanisms for which health research is not sure about, which is the case of dementia and comorbidities. 
Prognostic estimates not only work along with patients and physicians in what concerns, individually, the best 
treatments and therapies for a disease, but can also support health institutions as a decision-making support in what 
concerns patient-care programs in a population level. 
Given the importance of the dementia and comorbidity research, and motivated by the complex scenario 
presented, the aim of this paper is to present a systematic literature review that investigates how are these machine 
learning and microsimulation techniques being employed in the development of prognostic estimates for the before 
mentioned conditions. 
This paper is organized as follows: the Method section describes approach used for the systematic literature 
review; the Results section presents the conclusions of the summarized data from the selected studies; the 
Discussion section argue about the results and threats to the validity of the results; and the Conclusions and Future 
Work section presents final statements and plans for future works. 
2. Method 
A systematic literature review (SLR) is a well-defined methodology for the identification, evaluation and 
interpretation of the relevant published evidence related to certain research questions, topics of interest or events. 
Motivations to run this type of study are usually to summarize the existing evidence, identify gaps in a research area, 
provide a ground to position new research ideas, or to support (or contradict) a theoretical hypothesis14.15. It 
comprises the following steps15,16: 
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• Identify the need for performing the systematic review; 
• Formulate the review questions; 
• Perform a comprehensive and exhaustive search of primary studies; 
• Perform a quality assessment of the selected studies; 
• Identify the data needed to answer the research questions; 
• Extract the data from the studies; 
• Interpret the results to determine their applicability;  
• Report the findings. 
Within the context of this paper, five participants performed a systematic literature review: three professors with 
different domain expertise (machine learning, health and bioinformatics) and two doctoral students whose PhD 
research is inserted within the topics of this SLR. Two of the professors had previous experience in conducting 
SLRs. Prior to carrying out this SLR, all participants took part in producing the research protocol specifying the 
methods, strategies and questions to be answered. 
2.1. Research Questions 
The main question this study aims to answer is: “How are the machine learning and microsimulation techniques 
being employed by the researches on the prognosis of dementia and comorbidities?”. This main question was 
decomposed in the four research questions (RQ) below: 
• RQ 1: Which machine learning and microsimulation techniques are being used in the dementia and comorbidities 
research? 
• RQ 2: What data characteristics (variables, determinants and indicators) are being considered when applying the 
machine learning or and microsimulation techniques (physiological, demographic/social, genetics, lifestyle etc)? 
• RQ 3: What are the goals of the studies that employ machine learning or microsimulation techniques for 
prognosis of dementia and comorbidities? 
• RQ 4: Does the studies focus on individuals or populations? 
Given space limitations, this paper reports the SLR results for two of the four research questions – RQs 2 and 3, as 
both regard the dementia condition. 
2.2. Search String 
The search string used in the automated search was structured using the PICO approach16, in which the main 
question is decomposed into four parts: population of interest, intervention, comparison and outcome. For the 
present study, the “comparison” component was not used due to its nature being a characterization. The other 
components used for the automated searches are represented as follows:  
• Population: Studies that address researches on dementia and comorbidities. 
• Intervention: Machine learning or microsimulation techniques. 
• Outcome: Prognostic estimates on dementia and comorbidities at individual or population level. 
The search string was built up derived from each of the PICO components. For the dementia keywords, the health 
expert supervising the study made a selection on the “Systematized Nomenclature of Medicine - Clinical Terms†” 
ontology. Comorbidity synonyms were derived from a systematic literature review in this subject6. Prognosis 
synonyms were given by the health expert supervising the research. The machine learning keywords comprised the 
approaches contained in the “2012 ACM Computing Classification System‡”. Finally, for the microsimulation 
† The Systematized Nomenclature of Medicine - Clinical Terms: http://purl.bioontology.org/ontology/SNOMEDCT 
‡ The 2012 ACM Classification System: http://www.acm.org/about/class/2012
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keywords, given the novelty of this technique, it was not part of any classification system or review, so its synonyms 
were given by one of the doctoral students who is researching in this area.  
 The resulting string and other details concerning the automated searches are shown in the table 1. It is important 
to notice that the string was adapted to the search mechanisms of each of the selected sources. 
Table 1. Automated searches details 
Sources Socups, Pubmed ,Web of Science Search Date  October 23rd of 2015 
Resulting Search String 
"Dimentia" OR "Dementia" OR "Alzheimer" OR "Mixed Dementia" OR "Vascular Dementia" OR "Lewy Bodies" OR "Parkinson" OR 
"Creutzfeldt-Jakob" OR "Normal pressure hydrocephalus" OR "Huntington disease" OR "Wernicke-Korsakoff Syndrome" OR "Frontotemporal 
Dementia" OR "Neurosyphilis" OR "complex of Guam" OR "Subcortical leukoencephalopathy" OR "Comorbidities" OR "Comorbidity" OR 
"Co-morbidity" OR "multimorbidity" OR "multimorbidities" OR "multi-morbidity" ) AND ( "Machine Learning" OR "Data Mining" OR 
"Decision Support System" OR "Clinical Support System" ) AND ( "Classification" OR "Regression" OR "Kernel" OR "Support vector 
machines" OR "Gaussian process" OR "Neural networks" OR "Logical learning" OR "relational learning" OR "Inductive logic" OR "Statistical 
relational" OR "probabilistic graphical model" OR "Maximum likelihood" OR "Maximum entropy" OR "Maximum a posteriori" OR "Mixture 
model" OR "Latent variable model" OR "Bayesian network" OR "linear model" OR "Perceptron algorithm" OR "Factorization" OR "Factor 
analysis" OR "Principal component analysis" OR "Canonical correlation" OR "Latent Dirichlet allocation" OR "Rule learning" OR "Instance-
based" OR "Markov" OR "Stochastic game" OR "Learning latent representation" OR "Deep belief network" OR "Bio-inspired approach" OR 
"Artificial life" OR "Evolvable hardware" OR "Genetic algorithm" OR "Genetic programming" OR "Evolutionary robotic" OR "Generative and 
developmental approaches" OR "microsimulation" OR "micro-simulation" OR "microanalytic simulation" OR "agent-based modeling" ) AND ( 
"prognosis" OR "prognostic estimate" OR "predictor" OR "prediction" OR "model" OR "patterns" OR "diagnosis" OR "diagnostic" OR 
"Forecasting" OR "projection" 
2.3. Document selection, quality assessment and data extraction 
Fig. 1 outlines the #primary studies for the selection, quality assessment and data extraction phases of this SLR. 
Fig. 1. Study selection diagram
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The papers retrieved from the automated searches, in all of the selected sources, had their duplicates removed, 
and this set of possible primary studies was assessed by the evaluation of their titles and abstracts according to 
previously defined inclusion and exclusion criteria (see table 2). The two doctoral students took part in evaluating 
the titles and abstracts, and two professors acted in conflict resolution when an agreement regarding the selection of 
a paper could not be reached between the doctoral students. An evaluation round with a hundred papers was done on 
beforehand and supervised by one of the professors with previous experience conducting SLRs. This was done to 
maintain the consistency of the evaluation of titles and abstracts due to the high number of results retrieved. The 
result of the evaluations is the Selected Subset 1. Then, the reference list of the papers in the Selected Subset 1 was 
retrieved and evaluated by their titles and abstracts, like in the previous phase, resulting in the Selected Subset 2. 
Each one of the papers contained in the Selected Subsets 1 and 2 were fully read and assessed for its quality using 
a quality assessment questionnaire defined previously in the protocol (see table 3). To maintain the consistency in 
the grading of the quality assessment, a supervised assessment round was performed by the doctoral students and a 
professor. 
    Table 2. Inclusion and exclusion criteria 
Inclusion Criteria Exclusion Criteria
Be a primary study in English; AND 
Address research on dementia and comorbidities; AND
Address at least one machine learning or microsimulation 
technique; AND 
Address a prognosis related to dementia and comorbidities. 
Be a secondary or tertiary study; OR 
Be written in another language other than English; OR 
Do not address a research on dementia and comorbidities; OR 
Do not address at least one machine learning or microsimulation 
technique; OR 
Do not address a prognosis related to dementia and comorbidities. 
     Table 3. Quality assessment questionnaire 
Question Grading 
Are the aims of the study clearly stated? Yes=1; Partly=0.5; No=0 
Does the study describe clearly the population being studied? Yes=1; Partly=0.5; No=0 
Was the rationale for the sample size provided? Yes=1; Partly=0.5; No=0 
Is the sample representative of the population to which the results will generalize? Yes=1; Partly=0.5; No=0 
Were the limitations of the study reported either during the explanation of the study design or during the 
discussion of the study results? 
Yes=1; Partly=0.5; No=0 
Were the findings clearly reported? Yes=1; Partly=0.5; No=0 
Are the measures used in the study clearly defined? Yes=1; Partly=0.5; No=0 
Are the measures used in the study valid? Yes=1; Partly=0.5; No=0 
Is the data collection method clearly described? Yes=1; Partly=0.5; No=0 
Is/are the technique(s) being employed clearly described? Yes=1; Partly=0.5; No=0 
Was the statistical significance assessed? Yes=1; Partly=0.5; No=0 
Was a sensitivity analysis carried out to assess if the results were due to certain inputs? Yes=1; Partly=0.5; No=0 
Total 12 
The quality assessment was important in this SLR because there were a lot of papers that would focus on the 
techniques being used and not giving enough information about the data used, or the purpose of the paper was 
describing a health experiment, but the techniques used were overlooked. If a paper was graded below 8 in the 
quality assessment (the quality score range was between zero and 12), it was rejected for quality reasons. In this 
phase a paper could also be rejected by the inclusion and exclusion criteria, as it was adopted an inclusive approach 
during the selection by title and abstracts. It’s important to notice that, as seen in Fig. 1, a high number of papers 
were part of this exclusion case, but one factor that affected this number was the decision of removing papers that 
used solely statistical methods (i.e. principal component analysis), in building models. These will be analyzed 
separately in a future publication. 
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The papers that successfully passed the established criteria (inclusion and quality) were part of the Included 
Primary Studies set and had its relevant data extracted. A complete list of the included papers can be found on table 
S1 in the Supplementary Material. Conclusions derived from the aggregation of the extracted data will be shown in 
the Results section. 
3. Results 
 The summary data used to answer RQ2 and RQ3 3 is presented in the tables 4 and 5, respectively, and results 
are discussed in the sections below. 
3.1. RQ 2: What data characteristics (variables, determinants and indicators) are being considered when applying 
the machine learning or and microsimulation techniques (physiological, demographic/social, genetics, lifestyle etc)? 
 The final list of studies considered a variety of independent variables for learning. With regard to the dependent 
variables, most studies have considered a binary situation for prognosis of final stage of dementia progress, and 
some others have used a scale (such as MMSE) for this purpose. Table 4 only includes the independent variables. It 
is important to note that some of the variables (ADAS-cog) have been considered whether as dependent variable or 
independent variable in different studies, based on the study design. Also, the numbers (N) reported in Table 4 only 
include instances where a variable was part of the most accurate model(s). 
 Our SLR identified six major variables’ categories: neuroimaging (MRI , PET), cognitive measures 
(neuropsychological), CSF, blood marks, genetic, demographic (see table 4). Many of the studies considered more 
than one category, hence the Total per Category being sometimes smaller than the sum of its subcategories. The 
subcategory "other" represents different mixed subcategories, without any suggested as a major one. 
The two primary studies that used simulation approaches considered demographic and cognitive scores as input 
variables. Note that the numbers for categories that cover both machine learning and simulation methods detail how 
many studies on each category. 
 An important remark about the variables is that, as most of the studies employed neuroimaging in their analysis, 
in 26 out of the 37 studies, the analysed images came from the ADNI (Alzheimer’s Disease Neuroimaging 
Initiative) database.  
              Table 4. Data aggregation of the selected studies concerning the variables used 
Variable Category Variable Subcategory N 
NeuroImaging Total 35 
MRI 27 
PET 8 
Cognitive Measures Total 7 (of which 1 in simulation) 
MMSE 2 
ADAS-cog 2 
CDR 1 
FAQ 1 
 Buschke Cued Memory 1 
Other 1 
Genetic Total 5 
ApoE 5 
 family history 1 
CSF Total 7 
Lab Test Total 2 
blood marks 1 
other 1 
Demographic Total 7 (of which 2 in simulation) 
age 4 
other 3 
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3.2. RQ 3: What are the goals of the studies that employ machine learning or microsimulation techniques for 
prognosis of dementia and comorbidities? 
As shown in table 5, from the total of 37 selected studies, the vast majority (86.5%) aimed to analyze the 
conversion of mild cognitive impaired individuals to Alzheimer’s Disease. In the very few cases where the study 
goals varied, the target condition being studied was still Alzheimer, with the exception of two studies that were also 
concerned about Huntington’s Disease and cognitive impairment no dementia. Other types of dementia were 
targeted in one study of this set, precisely Frontotemporal Dementia and Lewy Body Dementia, but these conditions 
were not analyzed with respect to a prognosis estimate, so these were not included as studied conditions. 
Considering the type of data analysis technique employed in the studies, it could be noted that in both of the 
studies that employed microsimulation, the prognostic estimate being developed had a very clear purpose of 
investigating associated costs and cost-effectiveness of treatments. In studies that used machine learning, the 
developed prognostic models were more concerned about the investigation of the mechanisms of the conditions, and 
implications with costs, if any, were indirect. 
   Table 5. Data aggregation of the selected studies concerning its goals 
Study Goals Count Conditions Studied Type of Data Analysis  
Predict conversion from Mild Cognitive Impairment to 
Alzheimer’s Disease 
32 
Alzheimer's Disease, Mild 
Cognitive Impairment 
Machine Learning 
Predict conversion from Cognitive Impairment No Dementia 
to Alzheimer’s Disease 1 
Alzheimer's Disease, 
Cognitive Impairment No 
Dementia 
Machine Learning 
Predict disease stage through Mini Mental State Examination 
score 
1 
Alzheimer's Disease, Mild 
Cognitive Impairment 
Machine Learning 
Events-based fine-grained staging of patients 1 
Alzheimer's Disease, 
Huntington's Disease 
Machine Learning 
Evaluate screening and treatment to delay Alzheimer’s 
Disease 
1 Alzheimer's Disease Microsimulation 
Estimate the clinical course of mild Alzheimer’s Disease to 
Alzheimer’s Disease to death, and estimate costs 
(MEDICARE and nursing home utilization) 
1 
Alzheimer's Disease, Mild 
Cognitive Impairment 
Microsimulation 
4. Discussion 
The SLR results show that most of the dementia’s prognosis research goals is focused on the Alzheimer’s 
Disease. Reasons for this trend could be attributed to the fact that it is the most common type of dementia17 and also 
because it is the only disease among the leading cases of death to which research still could not assign neither a 
prevention strategy nor a disease modifying treatment18. Economic reasons could also be accounted for this high 
interest as studies show that the worldwide societal costs of dementia reached 604 billion of dollars in 201019. 
Additionally, it appears that the research on the prognosis of other types of dementia is being overlooked, and this 
should be carefully regarded because particularly in the case of Alzheimer’s Disease, studies show that mixed 
pathologies are more frequent than the “pure” ones, moreover other uncommon types of dementia (i.e. 
Frontotemporal Dementia) are typically misdiagnosed as Alzheimer’s19. 
The fact that so many studies make use of the ADNI database for predictions about the Alzheimer’s Disease can 
raise some questionings. First, not being a population-based study, the results derived from it may not be 
generalizable for other populations, also ADNI’s primary objective is to validate biomarkers20. Another point is that, 
although neuroimaging could potentially become a valid predictor for dementia, prognostic estimates require a 
multivariable approach21, and the SLR results have shown very few other types of variables being used. Lastly, 
being probably the most available database for Alzheimer’s studies, it raises a question that if neuroimaging is the 
best predictor for Alzheimer’s (and that is the why so many studies are focused on it) or is it because of the 
availability of data? 
With respect to the conducted SLR, major validity issues include: whether all the primary studies have been 
included in the final set and the superficial experience of the doctoral students in the topic of prognostic estimates. 
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To address the first issue, it was adopted an inclusive strategy, more specifically, as the selection of studies was 
based on the evaluation of titles and abstracts, when the abstracts were poorly written, if there was just a hint of the 
inclusion (and none of the exclusion criteria), it was selected to the posterior phase to be fully read, and then it is 
possible to be sure if it was fit to the purposes of the SLR. To address the second issue, whenever there was a study 
that the doctoral were not sure if it was fit to be a prognosis, the health supervisor of the SLR would make the 
decision. 
5. Conclusion and Future Work 
 This paper presents the results of the performed systematic literature review, which included 37 studies that 
approached the prognosis of dementia using machine learning or microsimulation techniques, and summarized its 
data concerning the variables used and the goals of the studies. The results showed trends in the research, that is 
mostly focused on predicting the conversion of mild cognitive impairment to Alzheimer’s Disease, in the case where 
machine learning was being used, and cost estimation, when microsimulation was the technique of choice. In what 
concerns the variables used, our results show that neuroimaging was the choice of most of the studies.
 The research provides a platform for further research in future to compare the performance of machine learning 
methods in prognosis of dementia, investigate the limitations in the performance comparison, and discover possible 
study gaps. 
 Future work includes a journal publication with further details of RQ2 and RQ3, presented in this papers, and 
the also the results and discussions regarding RQ 1 and RQ 4, which are concerned with the techniques used and if 
the study focused their predictions on an individual level or a population one, respectively.  
6. Supplementary Material 
 The supplementary material regarding this systematic literature review comprises the complete list of included 
studies, that can be found in this link: http://bth.diva-portal.org/smash/record.jsf?pid=diva2:916722.
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